PHOTOPHERESIS DURING KIDNEY TRANSPLANTATION
Abstract
The modern concept of patient’s post-transplantation care is focused on immunosuppression reduction where minimal side effects of these medications is registered and there is no rejection of renal allograft. Photopheresis is one of methods which inspire decrease of allograft rejection and immunotolerance formation.
About the Authors
A. P. Faenko
Moscow regional research and clinical institute named after M.F. Vladimirsky
Russian Federation
Russian Federation
Alexander P. Faenko, Senior Assistant of the Department of Clinical Transfusion.
Adress: 129110 Russia, Moscow, Shchepkina st., 61/2, build. 8.
A. V. Vatazin
Moscow regional research and clinical institute named after M.F. Vladimirsky
Russian Federation
Russian Federation
Andrey V. Vatazin, MD, PhD, Professor of medicine, DMedSci.
Head of the Department of Transplantation, Nephrology and Surgical hemocorrection.
Adress: 129110, Moscow, Shchepkin Str., 61/2, building 6.
A. V. Kildjushevskiy
Moscow regional research and clinical institute named after M.F. Vladimirsky
Russian Federation
Russian Federation
Alexander V. Kildushevskiy, Prof, MD, PhD, DMedSci.
Leading researcher of the department of Surgical hemocorrection and detoxifi cation.
Adress: 129110 Russia, Moscow, Shchepkina st., 61/2, build. 11.
V. V. Fedulkina
Moscow regional research and clinical institute named after M.F. Vladimirsky
Russian Federation
Russian Federation
Veronica A. Fedulkina MD, PhD,
Senior Researcher of the Surgical department of Transplantation and Dialysis.
Adress: 129110 Russia, Moscow, Shchepkina st., 61/2, build. 6.
References
1. Лубенников АЕ, Трушкин РН, Артюхина ЛЮ. Современные взгляды на проблему удаления почечного трансплантата. Московск хирург журн 2014; 4: 49-56 [Lubennikov AE, Trushkin RN, Artyukhina LY Sovremennye vzglyady na problemu udaleniya pochechnogo transplantata. Moskovskii khirurgicheskii zhurnal. 2014; 4: 49-56]
2. Johnston O, Rose C, Landsberg D et al. Nephrectomy after transplant failure: current practice and outcomes. Am J Transplant 2007; 7(8): 1961-1967. doi: 10.1111/j.1600-6143.2007.01884.x
3. Zambon JP, Magalhaes RS, Ko I et al. Kidney regeneration: Where we are and future perspectives. World J Nephrol 2014; 3(3): 24-30. doi: 10.5527/wjn.v3.i3.24
4. Yu H, Kim HS, Baek CH et al. Risk Factors for Hypertension After Living Donor Kidney Transplantation in Korea: A Multivariate Analysis. Transplant Proc 2016; 48(1): 88-91. doi: 10.1016/j.transproceed.2015.12.020
5. Peter W, Edelson RL. New Therapies for Cutaneous T-Cell Lymphoma. Arch Dermatol 1987; 123(2): 189-191. doi:10.1001/archderm.1987.01660260059012
6. Otman SG, Edwards C, Pearse AD et al. Modulation of ultraviolet (UV) transmission by emollients: relevance to narrowband UVB phototherapy and psoralen plus UVA photochemotherapy. Br J Dermatol 2006; 154(5): 963-8. doi: 10.1111/j.1365-2133.2006.07171.x
7. Jung AG, Bertsch HP, Schoen MP et al. A rare case of a sclerodermoid chronic graft versus host disease. Successful treatment with extracorporeal photopheresis (ECP). Hautarzt 2010; 61(6): 514-517. doi: 10.1007/s00105-010-1924-9
8. Andreu-Ullrich H. Miscellaneous indications for extracorporeal photochemotherapy (ECP). Transfus Apher Sci 2014;50(3): 363-369. doi: 10.1016/j.transci.2014.04.007
9. Adamski J, Kinard T, Ipe T et al. Extracorporeal photopheresis for the treatment of autoimmune diseases. Transfus Apher Sci 2015; 52(2): 171-182. doi: 10.1016/j.transci.2015.02.005
10. Knobler R, Berlin G, Calzavara-Pinton P et al. Guidelines on the use of extracorporeal photopheresis. J Eur Acad Dermatol Venereol 2014; 28(1): 1-37. doi: 10.1111/jdv.12311
11. Perotti C, Sniecinski I. A concise review on extracorporeal photochemotherapy: Where we began and where we are now and where are we going! Transfus Apher Sci 2015; 52(3): 360-368. doi: 10.1016/j.transci.2015.04.011
12. Schwartz J, Winters JL, Padmanabhan A et al. Guidelines on the use of therapeutic apheresis in clinical practice-evidencebased approach from the Writing Committee of the American Society for Apheresis: the sixth special issue. J Clin Apher 2013; 28(3): 145-284. doi: 10.1002/jca.21276
13. Costanzo-Nordin MR, Hubbell EA, O’Sullivan EJ et al. Successful treatment of heart transplant rejection with photopheresis. Transplantation 1992; 53(4): 808-815. doi: 10.1097/00007890199204000-00021
14. Barten MJ, Dieterlen MT. Extracorporeal photopheresis after heart transplantation. Immunotherapy 2014;6(8):927-944. doi: 10.2217/imt.14.69
15. Dieterlen MT, Bittner HB, Pierzchalski A et al. Immunological monitoring of extracorporeal photopheresis after heart transplantation. Clin Exp Immunol 2014; 176(1): 120-128. doi: 10.1111/cei.12254
16. Kapadia E, Wong E, Perez-Albuerne E et al. Extracorporeal photopheresis performed on the CELLEXR compared with the UVAR-XTSR instrument is more efficient and better tolerated in children with steroid-refractory graft-versus-host disease. Pediatr Blood Cancer 2015; 62(8): 1485-1488. doi: 10.1002/pbc.25487
17. Kitko CL, Levine JE. Extracorporeal photopheresis in prevention and treatment of acute GVHD. Transfus Apher Sci 2015; 52(2): 151-156. doi: 10.1016/j.transci.2015.02.001
18. Козлов АВ, Быкова ТА, Кулагина ИИ и др. Экстракорпоральный фотоферез в лечении реакции "трансплантат против хозяина". Гематол и трансфузиол 2014; 59(1): 47 [Kozlov AV, By`kova TA, Kulagina II i dr. E`kstrakorporal`ny`i` fotoferez v lechenii reaktcii "transplantat protiv hoziaina". Gematol i transfuziol 2014; 59(1): 47]
19. Calore E, Marson P, Pillon М et al. Treatment of Acute Graft-versus-Host Disease in Childhood with Extracorporeal Photochemotherapy/Photopheresis: The Padova Experience. Biol Blood Marrow Transplant 2015; 21(11): 1963-1972. doi: 10.1016/j.bbmt.2015.07.007
20. Benden C, Speich R, Hofbauer GF et al. Extracorporeal photopheresis after lung transplantation: a 10-year single-center experience. Transplantation 2008; 86(11): 1625-1627. doi: 10.1097/TP.0b013e31818bc024
21. Sato M, Waddell TK, Wagnetz U et al. Restrictive allograft syndrome (RAS): a novel form of chronic lung allograft dysfunction. J Heart Lung Transplant 2011; 30(7): 735-742. doi: 10.1016/j.healun.2011.01.712
22. Jaksch P, Scheed A, Keplinger M et al. A prospective interventional study on the use of extracorporeal photopheresis in patients with bronchiolitis obliterans syndrome after lung transplantation. J Heart Lung Transplant 2012; 31(9): 950-957. doi: 10.1016/j.healun.2012.05.002
23. Urbani L, Mazzoni A, Colombatto P et al. Potential applications of extracorporeal photopheresis in liver transplantation. Transplant Proc 2008; 40(4): 1175-1178. doi: 10.1016/j.transproceed.2008.03.071
24. Urbani L, Mazzoni A, Bianco I et al. The role of immunomodulation in ABO-incompatible adult liver transplant recipients. J Clin Apher 2008; 23(2): 55-62. doi: 10.1002/jca.20156
25. Urbani L, Mazzoni A, Bindi L et al. A single-staggered dose of calcineurin inhibitor may be associated with neurotoxicity and nephrotoxicity immediately after liver transplantation. Clin Transplant 2009; 23(6): 853-860. doi: 10.1111/j.13990012.2009.00957.x
26. Baron ED, Heeger PS, Hricik DE et al. Immunomodulatory effect of extracorporeal photopheresis after successful treatment of resistant renal allograft rejection. Photodermatol Photoimmunol Photomed 2001; 17(2): 79-82. doi: 10.1034/j.16000781.2001.017002079.x
27. Kusztal M, Kłak R, Krajewska M et al. Application of extracorporeal photopheresis in kidney transplant recipients: technical considerations and procedure tolerance. Transplant Proc 2011; 43(8): 2941-2942. doi: 10.1016/j.transproceed.2011.08.034
28. Федулкина ВА, Ватазин АВ, Кильдюшевский АВ и др. Трансляционная клеточная иммунотерапия при аллотрансплантации трупной почки у урологических больных. Альманах клин мед 2013; 28: 25-31 [Fedulkina V.A., Vatazin A.V., Kildyushevskii A.V. et al. Translational cellular immunotherapy for cadaveric kidney allograft in urological patients. Almanac of Clinical Medicine. 2013; 28: 25-31]
29. Кильдюшевский АВ, Федулкина ВА, Фомина ОА и др. Применение экстракорпоральной фотохимиотерапии при лимфомах кожи и трансплантации солидных органов. Альманах клин мед 2014; 30: 61-69 [Kildyushevsky AV, Fedulkina VA, Fomina OA et al. Application of extracorporeal photochemotherapy in skin lymphomas and transplantation of solid organs. Almanac of Clinical Medicine 2014; 30: 61-69]
30. Schmid D, Grabmer C, Streif D et al. T-cell death, phosphatidylserine exposure and reduced proliferation rate to validate extracorporeal photochemotherapy. Vox Sang 2015; 108(1): 8288. doi: 10.1111/vox.12200
31. Holtick U, Wang XN, Marshall SR et al. In vitro PUVA treatment preferentially induces apoptosis in alloactivated T cells. Transplantation 2012; 94(5): 31-34. doi: 10.1097/TP.0b013e31825f4454
32. Heshmati F. Updating ECP action mechanisms. Transfus Apher Sci 2014; 50(3): 330-339. doi: 10.1016/j.transci. 2014.04.003
33. Hannani D, Merlin E, Gabert F et al. Photochemotherapy induces a faster apoptosis of all reactive activated T cells than of nonalloreactive resting T cells in GvHD. Transplantation 2010; 90(11): 1232–1238. doi: 10.1097/TP.0b013e3181fa4eb6
34. Yoo EK, Rook AH, Elenitsas R et al. Apoptosis induction of ultraviolet light A and photochemotherapy in cutaneous T-cell Lymphoma: relevance to mechanism of therapeutic action. J Invest Dermatol 1996; 107(2): 235-242. doi: 10.1111/1523-1747.ep12329711
35. Setterblad N, Garban F, Weigl R et al. Extracorporeal photophoresis increases sensitivity of monocytes from patients with graft-versus-host disease to HLA-DR-mediated cell death. Transfusion 2007; 48(1): 169-177. doi: 10.1111/j.15372995.2007.01502.x
36. Usharauli D. Dendritic cells and the immunity/tolerance decision. Med Hypotheses 2005; 64(1): 112-113. doi: 10.1016/j.mehy.2004.02.061
37. Morelli AE. The immune regulatory effect of apoptotic cells and exosomes on dendritic cells: its impact on transplantation. Am J Transplant 2006; 6(2): 254-261. doi: 10.1111/j.16006143.2005.01197.x
38. Bittencourt MC, Perruche S, Contassot E et al. Intravenous injection of apoptotic leukocytes enhances bone marrow engraftment across major histocompatibility barriers. Blood 2001; 98(1): 224-230. doi: 10.1182/blood.V98.1.224
39. Kleinclauss F, Perruche S, Masson E et al. Intravenous apoptotic spleen cell infusion induces a TGF-beta-dependent regulatory T-cell expansion. Cell Death Differ 2005; 13(1): 41-52. doi:10.1038/sj.cdd.4401699
40. Morelli AE, Larregina AT, Shufesky WJ et al. Internalization of circulating apoptotic cells by splenic marginal zone dendritic cells: dependence on complement receptors and effect on cytokine production. Blood 2003; 101(2): 611-620. doi: 10.1182/blood-2002-06-1769
41. Hannani D, Merlin E, Gabert F et al. Photochemotherapy induces a faster apoptosis of alloreactive activated T cells than of nonalloreactive resting T cells in graft versus host disease. Transplantation 2010; 90(11): 1232-1238. doi: 10.1097/TP.0b013e3181fa4eb6
42. Peritt D. Potential mechanisms of action of photopheresis in hematopoietic stem cell transplantation. Biol Blood Marrow Transplantation 2006; 12: 7-12. doi: 10.1016/j.bbmt.2005.11.005
43. Martin PJ. Biology of chronic graft-versus-host disease: implications for a future therapeutic approach. Keio J Med 2008; 57(4): 177-183. doi: 10.2302/kjm.57.177
44. Iyoda T, Shimoyama S, Liu K et al. The CD8+ dendritic cell subset selectively endocytoses dying cells in culture and in vivo. J Exp Med 2002; 195(10): 1289-1302. doi: 10.1084/jem.20020161
45. Gorgun G, Miller KB, Foss FM. Immunologic mechanisms of extracorporeal photochemotherapy in chronic graftversushost disease. Blood 2002; 100(3): 941-947. doi: 10.1182/ blood-2002-01-0068
46. Baron ED, Heeger PS, Hricik DE et al. Immunomodulatory effect of extracorporeal photopheresis after successful treatment of resistant renal allograft rejection. Photodermatol Photoimmunol Photomed 2001; 17(2): 79-82. doi: 10.1034/j.16000781.2001.017002079.x
47. Inaba K, Turley S, Yamaide F et al. Efficient presentation of phagocytosed cellular fragments on the major histocompatibility complex class II products of dendritic cells. J Exp Med 1998; 188(11): 2163-2173. doi: 10.1084/jem.188.11.2163
48. Dhodapkar MV, Steinman RM. Antigen-bearing immature dendritic cells induce peptide-specific CD8(+) regulatory T cells in vivo in humans. Blood 2002; 100(1): 174-177. doi: 10.1182/blood.V100.1.174
49. Spisek R, Gasova Z, Bartunkova J. Maturation state of dendritic cells during the extracorporeal photopheresis and its relevance for the treatment of chronic graft-versus-host disease. Transfusion 2006; 46(1): 55-65. doi: 10.1111/j.15372995.2005.00670.x
50. Vogel I, Kasran A, Cremer J et al. CD28/CTLA-4/B7 costimulatory pathway blockade affects regulatory T-cell function in autoimmunity. Eur J Immunol 2015; 45(6): 1832-1841. doi: 10.1002/eji.201445190
51. Coutinho A, Caramalho I, Seixas E et al. Thymic commitment of regulatory T cells is a pathway of TCR-dependent selection that isolates repertoires undergoing positive or negative selection. Current Topics in Microbiology and Immunology 2005; 293: 43-71. doi: 10.1007/3-540-27702-1_3
52. Hu G, Liu Z, Zheng C et al. Antigen-non-specific regulation centered on CD25+Foxp3+ Treg cells. Cell Mol Immunol 2010; 7(6): 414-418. doi: 10.1038/cmi.2010.39
53. Viglietta V, Baecher-Allan C, Weiner HL et al. Loss of functional suppression by CD4+CD25+ regulatory T cells in patients with multiple sclerosis. J Exp Med 2004; 199(7): 971-979. doi: 10.1084/jem.20031579
54. Yang XF. Factors regulating apoptosis and homeostasis of CD4+ CD25(high) FOXP3+ regulatory T cells are new therapeutic targets. Front Biosci 2008; 13: 1472-1499. doi: 10.2741/2775
55. Dhaeze T, Peelen E, Hombrouck A et al. Circulating Follicular Regulatory T Cells Are Defective in Multiple Sclerosis. J Immunol 2015; 195(3): 832-840. doi: 10.4049/jimmunol.1500759
56. Hara M, Kingsley CI, Niimi M et al. IL-10 is required for regulatory T cells to mediate tolerance to alloantigens in vivo. J Immunol 2001; 166(6): 3789-3796. doi: 10.4049/jimmunol.166.6.3789
57. Cohen JL, Trenado A, Vasey D et al. CD4(+)CD25(+) immunoregulatory T Cells: new therapeutics for graft-versushost disease. J Exp Med 2002; 196(3): 401-406. doi: 10.1084/jem.20020090
58. Biagi E, Di Biaso I, Leoni V et al. Extracorporeal photochemotherapy is accompanied by increasing levels of circulating CD4+CD25+GITR+Foxp3+CD62L+ functional regulatory T-cells in patients with graft-versus-host disease. Transplantation 2007; 84(1): 31-39
59. Meloni F, Cascina A, Miserere S et al. Peripheral CD4(+) CD25(+) TREG cell counts and the response to extracorporeal photopheresis in lung transplant recipients. Transplant Proc 2007; 39(1): 213-217. doi: 10.1016/j.transproceed.2006.10.227
Review
For citations:
Faenko A.P., Vatazin A.V., Kildjushevskiy A.V., Fedulkina V.V. PHOTOPHERESIS DURING KIDNEY TRANSPLANTATION. Nephrology (Saint-Petersburg). 2016;20(6):42-48. (In Russ.)
Views:
729
Email this article 